Core Insights - BTQ Technologies Corp. has introduced the Quantum Stablecoin Settlement Network (QSSN), aimed at securing stablecoin platforms against quantum computing cybersecurity threats [2][5][7] - The stablecoin market has surpassed $225 billion, with increasing institutional demand and regulatory clarity driving adoption [5][7][16] - The QSSN framework is designed to help banks and digital asset platforms issue and manage stablecoins while complying with emerging quantum security mandates [8][12][18] Company Overview - BTQ Technologies is a global quantum technology company focused on securing mission-critical networks and has a decade-long collaboration with NIST to propose technical standards for quantum security [2][18] - The company aims to position itself as a critical technology provider for secure and scalable digital finance, particularly in the stablecoin and tokenized asset markets [5][12][19] Market Context - The stablecoin sector is rapidly evolving, with governments introducing new requirements to ensure long-term security in response to quantum computing advancements [7][8][16] - The GENIUS Act is advancing through Congress, seeking to establish federal guidelines for fiat-backed stablecoins, reinforcing the need for secure digital currency infrastructure [17][18] Technological Solution - QSSN will enable a quantum-secure version of JPMorgan's proposed USD deposit token (JPMD), allowing compliance with U.S. federal cybersecurity standards without altering existing token standards [5][9][10] - The framework enhances security for core stablecoin functions while maintaining compatibility with existing payment systems and compliance processes [12][15] Future Outlook - BTQ's QSSN is positioned to capitalize on the growing demand for quantum-proof financial infrastructure, providing a scalable, revenue-generating platform for stablecoin issuance and management [5][19] - The anticipated approval of the GENIUS Act will formalize digitized money as part of the financial system, creating further opportunities for BTQ and the stablecoin market [17][18]

The company is recognized for driving AI-ready infrastructure, strategic innovation, and sustainable growth in Taiwan's fast-evolving data center market.SAN ANTONIO, June 24, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Chunghwa Telecom has been recognized with the 2025 Taiwan Competitive Strategy Leadership Award in the data center services industry for its outstanding achievements in strategy development, infrastructure modernization, and customer-centric innovation. This recognition ...

Ryan Heuser, Co-Founder and Former President of Paul Frank Industries, Is Pura Vida's New CEO LOS ANGELES, June 24, 2025 /PRNewswire/ -- Affiliates of CriticalPoint announced today the acquisition of consumer wearables brand Pura Vida© Bracelets ("Pura Vida") from Vera Bradley, Inc. (NASDAQ: VRA). Under CriticalPoint's ownership and operational expertise, Ryan Heuser, co-founder and former president of Paul Frank Industries ("Paul Frank"), has joined Pura Vida as the company's new chief executive officer, e ...

Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC HOUSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces a comprehensive restructuring of its pre ...

Core Insights - Nektar Therapeutics announced statistically significant results from the Phase 2b REZOLVE-AD study of rezpegaldesleukin for atopic dermatitis, achieving primary and key secondary endpoints at week 16 [1][3][4] - The study demonstrated a rapid onset of Eczema Area and Severity Index (EASI) reduction and itch improvement, indicating the potential of rezpegaldesleukin as a first-in-class immune-modulator [1][7] - The safety profile of rezpegaldesleukin was consistent with previous reports, with the most common adverse events being mild to moderate injection site reactions [12][13] Study Design and Results - The global Phase 2b study involved 393 patients with moderate-to-severe atopic dermatitis, randomized to receive different dosing regimens of rezpegaldesleukin or placebo [2][18] - At week 16, the high dose (24 µg/kg every two weeks) showed a mean improvement in EASI score of 61%, while the middle and low doses showed improvements of 58% and 53%, respectively, all statistically significant compared to placebo [8][12] - Key secondary endpoints, including EASI-75 and EASI-90, also achieved statistical significance, with 42% and 25% of patients in the high dose group achieving these reductions, respectively [4][6] Efficacy and Biomarkers - The study revealed a robust dose-dependent reduction in inflammatory biomarkers associated with atopic dermatitis, including IL-19 and TARC/CCL17, with a notable increase in total regulatory T cells (Tregs) in the high dose group [9][10] - The results suggest that rezpegaldesleukin may offer a new therapeutic approach for treating dermatological diseases, with ongoing studies expected to provide further insights [9][10] Future Developments - Nektar plans to present the 16-week induction results at a medical conference later in 2025 and anticipates top-line data for alopecia areata in Q4 2025 [11][21] - The FDA granted Fast Track designation for rezpegaldesleukin for treating moderate-to-severe atopic dermatitis, indicating the potential for expedited development [21][22]

I often talk with family & friends about the idea of owning REITs ( XLRE ) but they always scoff at the idea. Instead, most talk about owning physical rental properties, thinking this is the only way to generate cash flow.Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their o ...

Group 1 - The article highlights the increasing complexity and uncertainty in the global macroeconomic environment, which has been a recurring theme in discussions throughout the year [1] - iREIT on Alpha offers in-depth research on various investment vehicles including REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives, emphasizing the value of their research services [1] Group 2 - The article does not provide specific company or industry insights, focusing instead on the general investment landscape and the services offered by iREIT on Alpha [2][3]

Since opening its doors at the corner of South Boulevard and 33rd St. in 2015, Natural Grocers has been a trusted source for high-quality, affordable organic and natural groceries, supplements, and household essentials for South Edmond, Oklahoma Christian University students, University of Central Oklahoma students, and the communities of Witcher, Lake Aluma, and Arcadia. The company, founded in 1955, remains committed to its Five Founding Principles providing: Nutrition Education, Quality Products, Always ...

Please consider following my new X/Twitter account for reaction to market developments and news.I'm a full-time investor with a strong focus on the tech sector. I graduated with a Bachelor of Commerce Degree with Distinction, major in Finance. I'm also a proud lifetime member of the Beta Gamma Sigma International Business Honour Society.My core values are: Excellence, Integrity, Transparency, & Respect. I always, to the best of my ability, hold true to these values which I believe are key for long-term succ ...

SAN DIEGO, CALIFORNIA - APRIL 24: Vehicles for sale are parked in a lot at a CarMax dealership on ... More April 24, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)Getty ImagesCarMax (NYSE:KMX) stock surged nearly 6% during trading on Friday. These gains were driven by the company reporting better-than-expected Q1 results, with revenue rising around 6% year-over-year to $7.55 billion, aligning with estimates, while earnings exceeded predictions at $1.38 per share. CarMax experienced a 6. ...